Sara Amicone

980 total citations · 3 hit papers
15 papers, 194 citations indexed

About

Sara Amicone is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Sara Amicone has authored 15 papers receiving a total of 194 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Sara Amicone's work include Diabetes Treatment and Management (4 papers), Acute Myocardial Infarction Research (4 papers) and Cardiac Imaging and Diagnostics (3 papers). Sara Amicone is often cited by papers focused on Diabetes Treatment and Management (4 papers), Acute Myocardial Infarction Research (4 papers) and Cardiac Imaging and Diagnostics (3 papers). Sara Amicone collaborates with scholars based in Italy, Belgium and United States. Sara Amicone's co-authors include Matteo Armillotta, Carmine Pizzi, Alberto Foà, Luca Bergamaschi, Pasquale Paolisso, Angelo Sansonetti, Andrea Impellizzeri, Dobrin Vassilev, Emanuele Barbato and Emanuele Gallinoro and has published in prestigious journals such as European Heart Journal, Pharmacology & Therapeutics and Cardiovascular Diabetology.

In The Last Decade

Sara Amicone

7 papers receiving 193 citations

Hit Papers

Infarct size, inflammatory burden, and admission hypergly... 2022 2026 2023 2024 2022 2025 2025 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry
    2022 125 citations Pasquale Paolisso, Luca Bergamaschi et al. Cardiovascular Diabetology profile →
  2. Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure
    2025 26 citations Matteo Armillotta, Emanuel Raschi et al. Pharmacology & Therapeutics profile →
  3. Prevention of atrial fibrillation with SGLT2 inhibitors across the spectrum of cardiovascular disorders: a meta-analysis of randomized controlled trials
    2025 14 citations Sara Amicone, Milena Leo et al. European Heart Journal - Cardiovascular Pharmacotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Amicone Italy 4 107 100 46 43 28 15 194
Angelo Sansonetti Italy 4 127 1.2× 120 1.2× 45 1.0× 52 1.2× 40 1.4× 14 218
Andrea Impellizzeri Italy 3 77 0.7× 88 0.9× 42 0.9× 39 0.9× 23 0.8× 9 154
Kristian Løkke Funck Denmark 12 117 1.1× 109 1.1× 32 0.7× 54 1.3× 41 1.5× 25 291
Alexander Peikert United States 8 133 1.2× 50 0.5× 36 0.8× 36 0.8× 10 0.4× 20 237
Qirui Song China 8 132 1.2× 116 1.2× 27 0.6× 40 0.9× 38 1.4× 15 266
Silvia Prosperi Italy 9 170 1.6× 63 0.6× 38 0.8× 61 1.4× 32 1.1× 28 238
Bas Langeveld Netherlands 7 129 1.2× 52 0.5× 65 1.4× 66 1.5× 19 0.7× 12 218
Gideon Valstar Netherlands 12 231 2.2× 63 0.6× 55 1.2× 52 1.2× 42 1.5× 17 323
U Bhalraam United Kingdom 7 143 1.3× 63 0.6× 74 1.6× 93 2.2× 34 1.2× 16 267
Michael Egstrup Denmark 8 153 1.4× 74 0.7× 43 0.9× 26 0.6× 21 0.8× 12 212

Countries citing papers authored by Sara Amicone

Since Specialization
Citations

This map shows the geographic impact of Sara Amicone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Amicone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Amicone more than expected).

Fields of papers citing papers by Sara Amicone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Amicone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Amicone. The network helps show where Sara Amicone may publish in the future.

Co-authorship network of co-authors of Sara Amicone

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Amicone. A scholar is included among the top collaborators of Sara Amicone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Amicone. Sara Amicone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Amicone, Sara, Milena Leo, Marco Basile, et al.. (2025). Prevention of atrial fibrillation with SGLT2 inhibitors across the spectrum of cardiovascular disorders: a meta-analysis of randomized controlled trials. European Heart Journal - Cardiovascular Pharmacotherapy. 11(5). 441–450. 14 indexed citations breakdown →
2.
Amicone, Sara, et al.. (2025). Revascularization in latecomer ST-elevation myocardial infarction patients: diverging ACC/AHA and ESC Guidelines. European Heart Journal. 47(12). 1432–1434.
3.
Leo, Milena, Marco Basile, Francesco Angeli, et al.. (2025). Cardiac magnetic resonance imaging in myocardial infarction with non-obstructive coronary arteries (MINOCA): current and evolving perspectives. Expert Review of Cardiovascular Therapy. 23(12). 765–775.
4.
Armillotta, Matteo, Emanuel Raschi, Guido Di Dalmazi, et al.. (2025). Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure. Pharmacology & Therapeutics. 270. 108861–108861. 26 indexed citations breakdown →
5.
6.
7.
Suma, Nicole, Sara Amicone, Angelo Sansonetti, et al.. (2023). Diagnostic agreement between echocardiography and second-level imaging techniques in patients with cardiac masses. European Heart Journal. 44(Supplement_2).
8.
Armillotta, Matteo, Sara Amicone, Luca Bergamaschi, et al.. (2023). Predictive value of Killip classification in MINOCA patients. European Journal of Internal Medicine. 117. 57–65. 23 indexed citations
9.
Angeli, Francesco, Michele Fabrizio, Pasquale Paolisso, et al.. (2022). Classificazione, caratteristiche cliniche e strategie diagnostiche delle masse cardiache. Giornale italiano di cardiologia. 23(8). 620–630. 1 indexed citations
10.
Paolisso, Pasquale, Luca Bergamaschi, Gaetano Santulli, et al.. (2022). Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry. Cardiovascular Diabetology. 21(1). 77–77. 125 indexed citations breakdown →
11.
Sansonetti, Angelo, Luca Bergamaschi, Gaetano Santulli, et al.. (2022). 866 INFARCT SIZE, INFLAMMATORY BURDEN AND ADMISSION HYPERGLYCEMIA IN DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH SGLT2-INHIBITORS: A MULTICENTER INTERNATIONAL REGISTRY. European Heart Journal Supplements. 24(Supplement_K). 3 indexed citations
12.
Impellizzeri, Andrea, Sara Amicone, Matteo Armillotta, et al.. (2022). Prognostic role and predictors of high Killip class in myocardial infarction with non-obstructive coronary artery. European Heart Journal. 43(Supplement_2).
13.
Sansonetti, Angelo, Sara Amicone, Luca Bergamaschi, et al.. (2022). 1054 GENDER DIFFERENCES IN MINOCA POPULATION. European Heart Journal Supplements. 24(Supplement_K).
14.
Armillotta, Matteo, Luca Bergamaschi, Sara Amicone, et al.. (2022). Prognostic role of early cardiac magnetic resonance in myocardial infarction with non-obstructive coronary arteries. European Heart Journal. 43(Supplement_2). 2 indexed citations
15.
Impellizzeri, Andrea, Nicole Suma, Francesco Palermo, et al.. (2021). 742 Myocarditis after SARS-CoV-2 vaccine: is that so simple?. European Heart Journal Supplements. 23(Supplement_G).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelo Sansonetti Breakdown of academic impact, for papers by Andrea Impellizzeri Breakdown of academic impact, for papers by Kristian Løkke Funck Breakdown of academic impact, for papers by Alexander Peikert Breakdown of academic impact, for papers by Qirui Song Breakdown of academic impact, for papers by Silvia Prosperi Breakdown of academic impact, for papers by Bas Langeveld Breakdown of academic impact, for papers by Gideon Valstar Breakdown of academic impact, for papers by U Bhalraam Breakdown of academic impact, for papers by Michael Egstrup
Rankless by CCL
2026